Drug companies claim that off-label drug promotion is protected by freedom of speech.

Continuous monitoring of pharma products with an innovative matchbox-sized laser

Do Brazilian wasps hold the promise of a new anticancer therapy? The answer is in the sting

Drug makers and regulators are taking steps towards transparency, but is it enough?

Dissecting a ligand into smaller fragments can provide a strategy for analyzing the role of key functional groups in a protein-ligand interaction.

It is well established that the use of nanotechnology in medicine and more specifically drug delivery is spreading rapidly.

The techniques of laser diffraction and automated particle imaging support the fast, cost-effective development of nasal spray products, simultaneously providing the data required for regulatory compliance. This paper examines their application.

Abusers are finding ways to circumvent current abuse-deterrent measures, leaving companies in need of new strategies.

Farid and her team have developed a range of software tools to help biopharma companies make decisions on the best manufacturing processes.

Several companies are faced with recall woes thanks to insects, dodgy closures and broken tablets.